Ownership history in Bridgefront Capital, LLC · 3 quarters on record
This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 6,305 | -4,431 | -41.3% | 0.09% | $299K | — |
| 2025 Q1 | REDUCED | 10,736 | -1,363 | -11.3% | 0.13% | $435K | — |
| 2021 Q2 | INITIATED | 12,099 | — | — | 0.11% | $300K | — |